Fundacion Aiken De La Comunitat Valenciana

At Fundacion Aiken De La Comunitat Valenciana, the clinical trial portfolio is centered on ophthalmology and eye diseases, with a strong focus on conditions that affect central vision and retinal health. The studies are designed to explore new treatment options and better understand how to slow disease progression in people living with dry age-related macular degeneration.

• Research on Dry Age-Related Macular Degeneration aims to evaluate whether new therapies can help preserve vision and improve outcomes for patients.
• Studies in Geographic Atrophy are examining ways to reduce lesion growth and address advanced retinal damage linked to age-related macular degeneration.
• The trials also assess the safety and effectiveness of emerging treatments intended to offer better disease control than current options.

Overall, the site’s research in Valencia is focused on advancing therapies for progressive retinal disease, with the goal of improving care for adults affected by macular degeneration and related vision loss.